These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 17028394)
41. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949 [TBL] [Abstract][Full Text] [Related]
42. Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome. Lee JS; Tartaglia M; Gelb BD; Fridrich K; Sachs S; Stratakis CA; Muenke M; Robey PG; Collins MT; Slavotinek A J Med Genet; 2005 Feb; 42(2):e11. PubMed ID: 15689434 [No Abstract] [Full Text] [Related]
43. A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins. Nyström AM; Ekvall S; Strömberg B; Holmström G; Thuresson AC; Annerén G; Bondeson ML Acta Paediatr; 2009 Apr; 98(4):693-8. PubMed ID: 19120036 [TBL] [Abstract][Full Text] [Related]
44. No mutation in the gene for Noonan syndrome, PTPN11, in 18 patients with Costello syndrome. Tröger B; Kutsche K; Bolz H; Lüttgen S; Gal A; Almassy Z; Caliebe A; Freisinger P; Hobbiebrunken E; Morlot M; Stefanova M; Streubel B; Wieczorek D; Meinecke P Am J Med Genet A; 2003 Aug; 121A(1):82-4. PubMed ID: 12900909 [No Abstract] [Full Text] [Related]
45. Autoimmune liver disease in Noonan Syndrome. Loddo I; Romano C; Cutrupi MC; Sciveres M; Riva S; Salpietro A; Ferraù V; Gallizzi R; Briuglia S Eur J Med Genet; 2015 Mar; 58(3):188-90. PubMed ID: 25595571 [TBL] [Abstract][Full Text] [Related]
46. Clinical and molecular characterization of 40 patients with Noonan syndrome. Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287 [TBL] [Abstract][Full Text] [Related]
49. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Razzaque MA; Nishizawa T; Komoike Y; Yagi H; Furutani M; Amo R; Kamisago M; Momma K; Katayama H; Nakagawa M; Fujiwara Y; Matsushima M; Mizuno K; Tokuyama M; Hirota H; Muneuchi J; Higashinakagawa T; Matsuoka R Nat Genet; 2007 Aug; 39(8):1013-7. PubMed ID: 17603482 [TBL] [Abstract][Full Text] [Related]
50. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Kratz CP; Niemeyer CM; Castleberry RP; Cetin M; Bergsträsser E; Emanuel PD; Hasle H; Kardos G; Klein C; Kojima S; Stary J; Trebo M; Zecca M; Gelb BD; Tartaglia M; Loh ML Blood; 2005 Sep; 106(6):2183-5. PubMed ID: 15928039 [TBL] [Abstract][Full Text] [Related]
54. Mutation analysis of PTPN11 in Noonan syndrome by WAVE. Elanko N; Jeffery S Methods Mol Med; 2006; 126():97-111. PubMed ID: 16930008 [TBL] [Abstract][Full Text] [Related]
55. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Tartaglia M; Cordeddu V; Chang H; Shaw A; Kalidas K; Crosby A; Patton MA; Sorcini M; van der Burgt I; Jeffery S; Gelb BD Am J Hum Genet; 2004 Sep; 75(3):492-7. PubMed ID: 15248152 [TBL] [Abstract][Full Text] [Related]
56. [Regulation of the immune system by protein tyrosine phosphatases]. Mizuno K; Yakura H Seikagaku; 2005 Oct; 77(10):1281-90. PubMed ID: 16296320 [No Abstract] [Full Text] [Related]
57. Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications. Lee WH; Raas-Rotschild A; Miteva MA; Bolasco G; Rein A; Gillis D; Vidaud D; Vidaud M; Villoutreix BO; Parfait B Proteins; 2005 Jan; 58(1):7-13. PubMed ID: 15521065 [TBL] [Abstract][Full Text] [Related]
58. Germline KRAS mutations cause Noonan syndrome. Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405 [TBL] [Abstract][Full Text] [Related]
59. A new mutation in the C-SH2 domain of PTPN11 causes Noonan syndrome with multiple giant cell lesions. Carapito R; Paul N; Untrau M; Ott L; Corradini N; Poignant S; Geffroy L; Caldagues E; Heymann MF; Cassagnau E; Isidor B; Bahram S J Hum Genet; 2014 Jan; 59(1):57-9. PubMed ID: 24225993 [TBL] [Abstract][Full Text] [Related]
60. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation. Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]